Adenosine 2A receptor–dependent activation of AMPK represses T H 17 cell pathogenicity through epigenetic and metabolic reprogramming
Science Signaling · 2025
DOI: 10.1126/scisignal.adr3177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Gina Papadopoulou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Immunology Laboratory, Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece. Hauptthemen laut MEDLINE: Receptor, Adenosine A2A, Th17 Cells, AMP-Activated Protein Kinases, Epigenesis, Genetic. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Metabolic reprogramming controls protective and pathogenic T helper 17 (T H 17) cell responses. When naïve T cells are differentiated into T H 17 cells in vitro, the presence of the cytokine activin A promotes their maturation into a nonpathogenic state. Here, we found that nonpathogenic T H 17 cells induced by activin A displayed reduced aerobic glycolysis and increased oxidative phosphorylation (OXPHOS). In response to activin A, signaling through the adenosine A 2A receptor (A 2A R) and AMP-activated protein kinase (AMPK) enhanced OXPHOS and reprogrammed pathogenic T H 17 cells toward nonpathogenic states that did not induce central nervous system autoimmunity in a mouse model of multiple sclerosis. In pathogenic T H 17 cells, the transcriptional coactivator p300/CBP-associated factor (PCAF) increased acetylation at histone 3 Lys 9 (H3K9ac) of genes involved in aerobic glycolysis and T H 17 pathogenic programs. In contrast, in nonpathogenic activin A–treated T H 17 cells, AMPK signaling suppressed PCAF-mediated H3K9ac modification of genes involved in aerobic metabolism and enhanced H3K9ac modification of genes involved in OXPHOS and nonpathogenic T H 17 programs. Together, our findings uncover A 2A R-AMPK signaling as a central metabolic checkpoint that suppresses T H 17 cell pathogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cellular Immunology Laboratory, Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
- Department of Genetics, Development, and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Molecular Biology Laboratory, Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
- Division of Immunology, Otto Loewi Research Center, Medical University of Graz, A-8010 Graz, Austria.
- School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.
- Division of Oncology, Otto Loewi Research Center, Medical University of Graz, A-8010 Graz, Austria.
ORCID-Profile: Gina Papadopoulou, Giannis Vatsellas, Marah C Runtsch, Marc Foretz, Benoit Viollet, Antonino Cassotta, Luke A J O'Neill, Georgina Xanthou
Zitieren
APA
Papadopoulou, G., Valakos, D., Polydouri, I., Moulara, A., Vatsellas, G., Angiari, S., Runtsch, M. C., Foretz, M., Viollet, B., Cassotta, A., O'Neill, L. A. J., & Xanthou, G. (2025). Adenosine 2A receptor–dependent activation of AMPK represses T H 17 cell pathogenicity through epigenetic and metabolic reprogramming. Science Signaling. https://doi.org/10.1126/scisignal.adr3177
Vancouver
Papadopoulou G, Valakos D, Polydouri I, Moulara A, Vatsellas G, Angiari S, et al. Adenosine 2A receptor–dependent activation of AMPK represses T H 17 cell pathogenicity through epigenetic and metabolic reprogramming. Science Signaling. 2025. doi:10.1126/scisignal.adr3177
BibTeX
@article{Papadopoulou2025,
author = {Papadopoulou, Gina and Valakos, Dimitrios and Polydouri, Ioanna and Moulara, Afroditi and Vatsellas, Giannis and Angiari, Stefano and Runtsch, Marah C and Foretz, Marc and Viollet, Benoit and Cassotta, Antonino and O'Neill, Luke A J and Xanthou, Georgina},
title = {Adenosine 2A receptor–dependent activation of AMPK represses T H 17 cell pathogenicity through epigenetic and metabolic reprogramming},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adr3177}
}
EUVIMED